| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.7K | $3.52M | - | |
| CFO | 88.9K | $2.36M | - | |
| Other | 79.9K | $2.12M | - | |
| Other | 79.9K | $2.12M | - | |
| VP | 50.5K | $1.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Kassberg Thomas Richard68 | Cbo &EVP | Sell | 11,509 | $49.93 | $574,644.37 | -4.4% | -13.5% | -21.0% | |
| Mar 7, 2024 | Fust Matthew K77 | Director | Sell | 12,195 | $50.88 | $620,442.75 | -16.5% | -18.5% | -24.1% | |
| Mar 1, 2024 | Parschauer Karah Herdman77 | EVP And Chief Legal Officer | Sell | 3,756 | $53.76 | $201,922.56 | -5.3% | -28.0% | -20.1% | |
| Mar 1, 2024 | Kassberg Thomas Richard68 | Cbo &EVP | Sell | 1,011 | $53.76 | $54,351.36 | -0.4% | -28.0% | -20.1% | |
| Mar 1, 2024 | Pinion John Richard73 | See Remarks | Sell | 4,173 | $53.76 | $224,340.48 | -4.5% | -28.0% | -20.1% | |
| Mar 1, 2024 | Huizenga Theodore Alan65 | SVP, Chief Accounting Officer | Sell | 341 | $53.76 | $18,332.16 | -0.8% | -28.0% | -20.1% | |
| Mar 1, 2024 | Crombez Eric74 | EVP And Chief Medical Officer | Sell | 1,238 | $53.76 | $66,554.88 | -2.5% | -28.0% | -20.1% | |
| Mar 1, 2024 | Harris Erik75 | EVP &Chief Commercial Officer | Sell | 4,768 | $53.76 | $256,327.68 | -6.6% | -28.0% | -20.1% | |
| Feb 7, 2024 | Kakkis Emil D72 | President &CEO | Sell | 30,000 | $45.00 | $1,350,000.00 | -5.3% | -6.2% | +2.4% | |
| Dec 29, 2023 | Kakkis Emil D72 | President &CEO | Sell | 30,000 | $47.87 | $1,436,100.00 | -5.0% | -2.4% | -9.2% |